In last trading session, ObsEva SA (NASDAQ:OBSV) saw 1.2 million shares changing hands with its beta currently measuring 0.27. Company’s recent per share price level of $0.16 trading at $0.0 or -3.12% at ring of the bell on the day assigns it a market valuation of $14.36M. That closing price of OBSV’s stock is at a discount of -1943.75% from its 52-week high price of $3.27 and from its 52-week low price of $0.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.58 million shares which gives us an average trading volume of 2.64 million if we extend that period to 3-months.
For ObsEva SA (OBSV), analysts’ consensus is at an average recommendation of a Hold while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.19 in the current quarter.
ObsEva SA (NASDAQ:OBSV) trade information
Upright in the red during last session for losing -3.12%, in the last five days OBSV remained trading in the red while hitting it’s week-highest on Thursday, 09/15/22 when the stock touched $0.16 price level, adding 11.65% to its value on the day. ObsEva SA’s shares saw a change of -92.21% in year-to-date performance and have moved -12.62% in past 5-day. ObsEva SA (NASDAQ:OBSV) showed a performance of -25.97% in past 30-days. Number of shares sold short was 3.11 million shares which calculate 7.39 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $6.25 to the stock, which implies a rise of 97.44% to its current value. Analysts have been projecting $1.00 as a low price target for the stock while placing it at a high target of $12.00. It follows that stock’s current price would drop -7400.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -525.0% for stock’s current value.
ObsEva SA (OBSV) estimates and forecasts
Statistics highlight that ObsEva SA is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -88.25% of value to its shares in past 6 months, showing an annual growth rate of 16.67% while that of industry is 1.70. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 24.00% in the current quarter and calculating -1,900.00% decrease in the next quarter. This year revenue growth is estimated to fall -65.70% from the last financial year’s standing.
And 4 analysts are in estimates of company making revenue of $1.25 million in the next quarter that will end on Sep 2022. Company posted $4k and $20.1 million of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 5.30% during past 5 years.
ObsEva SA is more likely to be releasing its next quarterly report between March 03 and March 07 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
ObsEva SA (NASDAQ:OBSV)’s Major holders
Insiders are in possession of 5.25% of company’s total shares while institution are holding 24.18 percent of that, with stock having share float percentage of 25.52%. Investors also watch the number of corporate investors in a company very closely, which is 24.18% institutions for ObsEva SA that are currently holding shares of the company. Sofinnova Investments, Inc. is the top institutional holder at OBSV for having 4.75 million shares of worth $7.17 million. And as of Mar 30, 2022, it was holding 4.37% of the company’s outstanding shares.
The second largest institutional holder is NEA Management Company, LLC, which was holding about 4.59 million shares on Mar 30, 2022. The number of shares represents firm’s hold over 4.22% of outstanding shares, having a total worth of $6.93 million.
On the other hand, iShares NASDAQ Biotechnology ETF and SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 0.3 million shares of worth $0.49 million or 0.28% of the total outstanding shares. The later fund manager was in possession of 0.11 million shares on Jun 29, 2022, making its stake of worth around $0.18 million in the company or a holder of 0.10% of company’s stock.